Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity

The identification of molecular biomarkers in CSF from individuals affected by Huntington disease may help improve predictions of disease onset, better define disease progression and could facilitate the evaluation of potential therapies. The primary objective of our study was to investigate novel C...

Descripción completa

Detalles Bibliográficos
Autores principales: Caron, Nicholas S, Haqqani, Arsalan S, Sandhu, Akshdeep, Aly, Amirah E, Findlay Black, Hailey, Bone, Jeffrey N, McBride, Jodi L, Abulrob, Abedelnasser, Stanimirovic, Danica, Leavitt, Blair R, Hayden, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746690/
https://www.ncbi.nlm.nih.gov/pubmed/36523269
http://dx.doi.org/10.1093/braincomms/fcac309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746690/
https://www.ncbi.nlm.nih.gov/pubmed/36523269
http://dx.doi.org/10.1093/braincomms/fcac309

Ejemplares similares